Steris (STE) Tops Q4 EPS by 1c; Updates FY15 Outlook

Steris (NYSE: STE) reported Q4 EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $439.9 million versus the consensus estimate of $439.23 million.

Outlook

Based upon current trends and reflecting recently announced acquisitions, STERIS now anticipates revenue growth of 6-7% for fiscal 2016. Expectations for adjusted earnings per diluted share are unchanged in the range of $3.15 to $3.30 for the full fiscal year. The Company does anticipate approximately $0.06 accretion this fiscal year from the General Econopak and Black Diamond acquisitions, both of which have now closed. However, most of that benefit will be offset by additional interest expense from the recently completed private placement financing. The Company has assumed the average forward currency rates for the U.S. dollar and key international currencies as of June 30, 2015. The adjusted effective tax rate is anticipated to be approximately 35%.

For earnings history and earnings-related data on Steris (STE) click here.

You May Also Be Interested In

• Bristol-Myers Squibb (BMY) stock slips despite earnings beat
• EMCOR Group (EME) Tops Q1 EPS by 133c, raises guidance
• Union Pacific (UNP) Tops Q1 EPS by 18c